RediNews
ETFs Holding TROV »    TROV Historical Stock Prices »
TROV News Video: Thu, Mar 16, 2017, 1:06 PM — Thursday Sector Laggards: Defense, Biotechnology Stocks


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
TrovaGene is a clinical-stage medicine oncology therapeutics company. Co.'s main focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by using its Precision Cancer Monitoring® (PCM) technology in tumor genomics. Co.'s main drug candidate, PCM-075, is a Polo-like Kinase 1 selective adenosine triphosphate inhibitor. PCM-075 shown preclinical antitumor activity as a single agent and synergy in combination with more than 10 different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor. Self directed investors in TrovaGene Inc will be interested in keeping up with all TrovaGene Inc news they can find, both TROV news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on TROV. At RediNews, we simplify this task by presenting both TROV news releases originating from TrovaGene Inc itself, and TROV news from a variety of media outlets. Visitors can browse this news online and through our TROV RSS news feed.

TROV News

TROV News — Articles, Videos, & Press Releases

TROV is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

FGEN News
FLXN News
LOXO News
AGTC News
MRNS News
ALDR News
HYH News
SURG News
LBIO News
AGRX News

If you use web portal software to control the site content for your corporate portal or public internet directory and portal website, or even if you have zero experience with the notion of a dynamic stock feed for website or corporate portal sites, RediNews can be your financial tool provider of RSS headline news feeds. If you already have stock price pages, great, our RSS feed should fit right in and add another form of dynamic stock ticker specific content. Our news would go well next to intraday charts of the indexes or individual stocks, on an option chain page, or anywhere stock market data is found on your web site. You could even set up a ticker bar with a news ticker to complement a stock ticker. Depending on your level of web portal content experience, you can get really fancy with these feeds. Or even if you have no web page finance content experience yet and are just starting out integrating stock data, give our RSS feeds a try. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): .

TROV News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.